Chemoinformaics analysis of GALLOCATECHIN-(4ALPHA->8)-EPIGALLOCATECHIN
| Molecular Weight | 610.524 | nRot | 3 |
| Heavy Atom Molecular Weight | 584.316 | nRig | 34 |
| Exact Molecular Weight | 610.132 | nRing | 6 |
| Solubility: LogS | -3.823 | nHRing | 2 |
| Solubility: LogP | 1.331 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 70 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 44 | No. of Aromatic Carbocycles | 4 |
| nHetero | 14 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 24 |
| No. of Oxygen atom | 14 | No. of Arom Bond | 24 |
| nHA | 14 | APOL | 78.6646 |
| nHD | 12 | BPOL | 29.5554 |
| QED | 0.149 |
| Synth | 4.73 |
| Natural Product Likeliness | 1.878 |
| NR-PPAR-gamma | 0.892 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.021 |
| Pgp-sub | 0 |
| HIA | 0.986 |
| CACO-2 | -6.943 |
| MDCK | 0.00000394 |
| BBB | 0.003 |
| PPB | 0.822854 |
| VDSS | 0.556 |
| FU | 0.161092 |
| CYP1A2-inh | 0.012 |
| CYP1A2-sub | 0.084 |
| CYP2c19-inh | 0.008 |
| CYP2c19-sub | 0.038 |
| CYP2c9-inh | 0.269 |
| CYP2c9-sub | 0.314 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.164 |
| CYP3a4-inh | 0.036 |
| CYP3a4-sub | 0.22 |
| CL | 12.038 |
| T12 | 0.689 |
| hERG | 0.049 |
| Ames | 0.12 |
| ROA | 0.127 |
| SkinSen | 0.976 |
| Carcinogencity | 0.013 |
| EI | 0.91 |
| Respiratory | 0.016 |
| NR-Aromatase | 0.59 |
| Antiviral | Yes |
| Prediction | 0.820642 |